-
公开(公告)号:US20080146500A1
公开(公告)日:2008-06-19
申请号:US11573830
申请日:2005-08-11
申请人: Bengt Krister Bokvist , John Philip Mayer , Lianshan Zhang , Jorge Alsina-Fernandez , Andrew Mark Vick
发明人: Bengt Krister Bokvist , John Philip Mayer , Lianshan Zhang , Jorge Alsina-Fernandez , Andrew Mark Vick
CPC分类号: A61K47/60
摘要: The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
摘要翻译: 本发明包括选择性活化VPAC2受体并可用于治疗糖尿病的肽。
-
公开(公告)号:US20080096811A1
公开(公告)日:2008-04-24
申请号:US11569362
申请日:2005-05-19
申请人: Bengt Krister Bokvist , Jesper Lindgren Gromada , Robert Chadwick Cummins , Wolfgang Glaesner , John Philip Mayer , Lianshan Zhang , Jorge Alsina-Fernandez
发明人: Bengt Krister Bokvist , Jesper Lindgren Gromada , Robert Chadwick Cummins , Wolfgang Glaesner , John Philip Mayer , Lianshan Zhang , Jorge Alsina-Fernandez
IPC分类号: A61K38/16 , A61P3/10 , C07K14/575
CPC分类号: C07K14/57563
摘要: The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
摘要翻译: 本发明包括选择性活化VPAC2受体并可用于治疗糖尿病的肽。
-
公开(公告)号:US20090118167A1
公开(公告)日:2009-05-07
申请号:US11573917
申请日:2005-08-11
申请人: Bengt Krister Bokvist , John Philip Mayer , Lianshan Zhang , Jorge Alsina-Fernandez , Andrew Mark Vick
发明人: Bengt Krister Bokvist , John Philip Mayer , Lianshan Zhang , Jorge Alsina-Fernandez , Andrew Mark Vick
IPC分类号: A61K38/17 , C07K14/475
CPC分类号: A61K47/60
摘要: The invention provides VPAC2R peptide agonists coupled to at least one polyethylene glycol molecule or derivative thereof, resulting in a biologically active peptide with an extended half-life and a slower clearance when compared to that of unPEGylated peptide.
摘要翻译: 本发明提供了与至少一种聚乙二醇分子或其衍生物偶联的VPAC2R肽激动剂,当与未PEG化肽相比时,产生具有延长的半衰期和较慢清除率的生物活性肽。
-
公开(公告)号:US20080194482A1
公开(公告)日:2008-08-14
申请号:US11997499
申请日:2006-07-28
IPC分类号: A61K38/17 , C07K14/435 , C07K7/06 , A61P3/10 , A61K38/08
CPC分类号: C07K14/57563 , A61K38/00
摘要: The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
摘要翻译: 本发明包括选择性活化VPAC2受体并可用于治疗糖尿病的肽。
-
公开(公告)号:US20080085860A1
公开(公告)日:2008-04-10
申请号:US11573896
申请日:2005-08-11
申请人: Bengt Krister Bokvist , John Phillip Mayer , Lianshan Zhang , Jorge Alsina-Fernandez , Andrew Mark Vick
发明人: Bengt Krister Bokvist , John Phillip Mayer , Lianshan Zhang , Jorge Alsina-Fernandez , Andrew Mark Vick
CPC分类号: C07K14/57563 , A61K38/00
摘要: The present invention encompasses PEGylated peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
摘要翻译: 本发明包括选择性活化VPAC2受体并可用于治疗糖尿病的聚乙二醇化肽。
-
公开(公告)号:US07897573B2
公开(公告)日:2011-03-01
申请号:US12508584
申请日:2009-07-24
IPC分类号: A61K38/16
CPC分类号: C07K14/4703 , A61K38/2278 , A61K47/60
摘要: The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
摘要翻译: 本发明包括选择性活化VPAC2受体并可用于治疗糖尿病的肽。
-
公开(公告)号:US07582608B2
公开(公告)日:2009-09-01
申请号:US12090656
申请日:2006-10-24
CPC分类号: C07K14/4703 , A61K38/2278 , A61K47/60
摘要: The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
摘要翻译: 本发明包括选择性激活VPAC2受体并可用于治疗糖尿病的肽。
-
公开(公告)号:US20080318845A1
公开(公告)日:2008-12-25
申请号:US11573903
申请日:2005-08-11
CPC分类号: A61K47/60
摘要: The present invention relates to peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
摘要翻译: 本发明涉及选择性活化VPAC2受体并可用于治疗糖尿病的肽。
-
公开(公告)号:US20080234198A1
公开(公告)日:2008-09-25
申请号:US12090656
申请日:2006-10-24
CPC分类号: C07K14/4703 , A61K38/2278 , A61K47/60
摘要: The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
-
公开(公告)号:US20090082276A1
公开(公告)日:2009-03-26
申请号:US12278337
申请日:2007-02-20
CPC分类号: C07K14/57563 , A61K38/00
摘要: The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
摘要翻译: 本发明包括选择性活化VPAC2受体并可用于治疗糖尿病的肽。
-
-
-
-
-
-
-
-
-